Team:Heidelberg

From 2009.igem.org

(Difference between revisions)
Line 480: Line 480:
=='''Project abstract'''==
=='''Project abstract'''==
-
Early efforts in synthetic biology have focused on using prokaryotes as an engineering
+
<p>Early efforts in synthetic biology have focused on using prokaryotes as an engineering
chassis, whereas novel developments indicate a shift towards an eukaryotic synthetic biology.
chassis, whereas novel developments indicate a shift towards an eukaryotic synthetic biology.
The value of eukaryotic synthetic biology is manifold: in medical research, it will accomplish
The value of eukaryotic synthetic biology is manifold: in medical research, it will accomplish
new ways of gene therapy; in plant biotechnology, it can contribute to the struggle for a
new ways of gene therapy; in plant biotechnology, it can contribute to the struggle for a
sustainable food and energy solution. Finally, the ability to assemble and analyze complicated
sustainable food and energy solution. Finally, the ability to assemble and analyze complicated
-
biological systems step by step will allow a revolutionary approach to fundamental research.
+
biological systems step by step will allow a revolutionary approach to fundamental research.</p>
Establishing new standards for iGEM, the Heidelberg 2009 team will be concerned with
Establishing new standards for iGEM, the Heidelberg 2009 team will be concerned with
developing ways for measuring promoters in mammalian cells, a default chassis and a first
developing ways for measuring promoters in mammalian cells, a default chassis and a first
Line 501: Line 501:
towards testing several anti-cancer drugs. A computer-based model will lay the foundations
towards testing several anti-cancer drugs. A computer-based model will lay the foundations
for future work. It will help us to build a logic that integrates the promoter activities and will allow us to predict the possibilities of a single functional output.
for future work. It will help us to build a logic that integrates the promoter activities and will allow us to predict the possibilities of a single functional output.
-
 
-
 
-
 
-
 
-
 
-
{|align="justify"
 
-
|You can write a background of your team here.  Give us a background of your team, the members, etc.  Or tell us more about something of your choosing.
 
-
|[[Image:Example_logo.png|200px|right|frame]]
 
-
|-
 
-
|
 
-
''Tell us more about your project.  Give us background.  Use this is the abstract of your project.  Be descriptive but concise (1-2 paragraphs)''
 
-
|[[Image:Team.png|right|frame|Your team picture]]
 
-
|-
 
-
|
 
-
|align="center"|[[Team:Heidelberg | Team Example]]
 
-
|}
 
-
 
-
<!--- The Mission, Experiments --->
 
-
 
-
{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center"
 
-
!align="center"|[[Team:Heidelberg|Home]]
 
-
!align="center"|[[Team:Heidelberg/Team|The Team]]
 
-
!align="center"|[[Team:Heidelberg/Project|The Project]]
 
-
!align="center"|[[Team:Heidelberg/Parts|Parts Submitted to the Registry]]
 
-
!align="center"|[[Team:Heidelberg/Modeling|Modeling]]
 
-
!align="center"|[[Team:Heidelberg/Notebook|Notebook]]
 
-
|}
 
-
(''Or you can choose different headings.  But you must have a team page, a project page, and a notebook page.'')
 

Revision as of 18:41, 16 July 2009

TITLE

Available Languages

Project abstract

Early efforts in synthetic biology have focused on using prokaryotes as an engineering chassis, whereas novel developments indicate a shift towards an eukaryotic synthetic biology. The value of eukaryotic synthetic biology is manifold: in medical research, it will accomplish new ways of gene therapy; in plant biotechnology, it can contribute to the struggle for a sustainable food and energy solution. Finally, the ability to assemble and analyze complicated biological systems step by step will allow a revolutionary approach to fundamental research.

Establishing new standards for iGEM, the Heidelberg 2009 team will be concerned with developing ways for measuring promoters in mammalian cells, a default chassis and a first evaluation of the recently postulated BioBrick beta proposal 2 (Tom Knight). Considering the importance of controlling gene expression, our team's work will focus on natural and synthetic mammalian promoters. Our vision is to provide the synthetic biology community with a methodical library of such promoters (with different output strength and sensitivity to different regulatory proteins) and a model which can provide guidance for the development of further synthetic promoters. Our efforts will therefore, from the very beginning, equally entail bioinformatics and wet lab work. As an early application for such a promoter library, our team will attempt to develop an assay which can monitor the activity of several pathways in one cell. Such an assay is of high value for biological research as it can be applied for studying stem cell differentiation, tumor formation, apoptosis and autophagy as well as drug response. Our team will apply the assay towards testing several anti-cancer drugs. A computer-based model will lay the foundations for future work. It will help us to build a logic that integrates the promoter activities and will allow us to predict the possibilities of a single functional output.